Cortagine is a synthetic peptide analog derived from corticotropin-releasing factor motifs, designed for receptor-binding and signaling investigations. Its sequence balances helical propensity with charged and aromatic residues. Researchers examine conformational ensembles and ligand-receptor contact patterns. Applications include neuropeptide-structure research, motif engineering, and biophysical interaction analysis.
CAT No: R2750
Cortagine is a synthetic peptide compound that functions as a selective agonist for the corticotropin-releasing factor type 1 (CRF1) receptor. As a tool molecule in neuroendocrinology and peptide signaling research, it enables precise modulation of CRF1-mediated pathways, offering significant value for studies investigating stress responses, neuropeptide signaling, and receptor pharmacology. Its well-characterized activity profile and receptor specificity make it an important reagent for dissecting the physiological and biochemical roles of corticotropin-releasing factor systems in both in vitro and in vivo experimental models.
Receptor Pharmacology: As a potent and selective CRF1 receptor agonist, cortagine is widely used to probe the functional dynamics of CRF signaling in various cellular and tissue-based assays. It provides a reliable means to activate CRF1 pathways, allowing researchers to study downstream signaling cascades, receptor desensitization, and ligand-receptor interactions in a controlled manner. This application is especially relevant for characterizing CRF1 receptor function in neuronal and endocrine cell lines, as well as for benchmarking the pharmacological profiles of novel CRF-targeted compounds.
Neuroendocrine Research: The peptide's ability to mimic endogenous corticotropin-releasing factor activity at the CRF1 receptor makes it a valuable tool for elucidating the molecular mechanisms underlying stress axis regulation. By selectively stimulating CRF1, cortagine enables detailed investigation of hypothalamic-pituitary-adrenal (HPA) axis activation, facilitating studies of hormone secretion dynamics, feedback regulation, and neuropeptide signaling under various experimental conditions. This supports the advancement of fundamental research into stress physiology and neuroendocrine integration.
Behavioral Studies: In behavioral neuroscience, cortagine is employed to model stress-related responses and evaluate the role of CRF1 receptor activation in animal paradigms. Its use allows researchers to induce and monitor behavioral phenotypes associated with anxiety, arousal, and adaptive responses, thereby providing insights into the neurobiological basis of affective and cognitive processes. Such studies contribute to a deeper understanding of the interplay between peptide signaling and behavioral adaptation in response to environmental challenges.
Peptide Structure-Activity Relationship (SAR) Analysis: The defined sequence and receptor selectivity of cortagine make it a reference compound for structure-activity relationship investigations within the CRF peptide family. By comparing the activity of cortagine with analogs, researchers can map critical residues involved in receptor binding and activation, informing the rational design of new peptide ligands with tailored pharmacological properties. This application is instrumental in advancing peptide engineering and drug discovery efforts targeting the CRF system.
Assay Development: The robust and predictable activity profile of cortagine supports its use in the development and validation of bioassays for CRF1 receptor function. It serves as a positive control in cell-based reporter assays, ligand binding studies, and high-throughput screening platforms, ensuring assay reliability and reproducibility. Its inclusion in assay workflows facilitates the identification and characterization of novel modulators of CRF1 signaling, thereby accelerating progress in neuropeptide pharmacology and receptor-targeted research.
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.